|
BR102022025291A2
(https=)
|
|
|
|
CL2025003851A1
(es)
|
|
Métodos de tratamiento de alzheimer utilizando un anticuerpo anti-abeta protofibril.
|
|
BR102023014872A2
(https=)
|
|
|
|
BR102023012440A2
(https=)
|
|
|
|
BR102023010976A2
(https=)
|
|
|
|
BR102023009641A2
(https=)
|
|
|
|
BR102023008688A2
(https=)
|
|
|
|
BR102023007252A2
(https=)
|
|
|
|
BR102023005164A2
(https=)
|
|
|
|
BR102023001877A2
(https=)
|
|
|
|
BR102022023461A2
(https=)
|
|
|
|
BR202022009269U2
(https=)
|
|
|
|
BR202022005961U2
(https=)
|
|
|
|
BR202022001779U2
(https=)
|
|
|
|
BR202022000931U2
(https=)
|
|
|
|
BY13172U
(https=)
|
|
|
|
BY13166U
(https=)
|
|
|
|
BY13144U
(https=)
|
|
|
|
BY13142U
(https=)
|
|
|
|
CN307045788S
(https=)
|
|
|
|
BY23963C1
(https=)
|
|
|
|
BY13176U
(https=)
|
|
|
|
BY13175U
(https=)
|
|
|
|
BY13174U
(https=)
|
|
|
|
BY13165U
(https=)
|
|
|